Frequency of HLA-A alleles in Japanese patients with head and neck cancer

Japanese Journal of Clinical Oncology

Volumn 29, Issue 11, 1999, Pages 535-540

  Eura, Masao ^a   Katsura, Fumihiro ^a   Oiso, Masatake ^a   Obata, Atsushi ^a   Nakano, Koji ^a   Masuyama, Keisuke ^a   Ishikawa, Takeru ^b  

^a KUMAMOTO UNIVERSITY   (Japan)

^b Allerg and Immunol Ctr of Kyushu   (Japan)

Author keywords

Head and neck cancer; HLA A alleles; Japanese; PCR SSOP

Indexed keywords

HLA A ANTIGEN;

ADULT; AGED; ALLELE; AMINO ACID SEQUENCE; ARTICLE; ASIAN; FEMALE; GENE FREQUENCY; GENETICS; HEAD AND NECK TUMOR; HUMAN; JAPAN; MALE; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; AMINO ACID SEQUENCE; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE FREQUENCY; HEAD AND NECK NEOPLASMS; HLA-A ANTIGENS; HUMANS; JAPAN; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION;

EID: 0033218724     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/29.11.535     Document Type: Article

References (11)

1. Fleischhauer K, Zino E, Mazzi B, Severini, GM, Benazzi E, Bordignon C. HLA-A*02 subtype distribution in Caucasians from northern Italy: identification of A*0220. Tissue Antigens 1996;48:673-9.
2. Rivoltini L, Loftus DJ, Barracchini K, Arienti F, Mazocchi A, Biddison WE, et al. Binding and presentation of peptides derived from melanoma antigens MART-1 and glycoprotein-100 by HLA-A2 subtypes. J Immunol 1996;156:3882-91.
3. Barouch D, Friede T, Stevanovic S, Tussey L, Smith K, Jones SR, et al. HLA-A2 subtypes are functionally distinct in peptide binding and presentation. J Exp Med 1995;182:1847-56.
4. Sudo T, Kamikawaji N, Kimura A, Date Y, Savoie J C, Nakashima H, et al.Differences in MHC class I self peptide repertoires among HLA-A2. subtypes. J Immunol 1995;155:4749-56.
5. Ohashi YM, Alosco S, Granja C, Salazar M, Hegland J, Yunis E. Accurate typing of HLA-A antigens and analysis of serological deficiencies. Tissue Antigens 1997;50:380-6.
6. Lorentzen DF, Iwanaga KK, Meuer KJ, Moritz TL, Watkins DI. A 25% error rate in serologic typing of HLA-B homozygotes. Tissue Antigens 1997;50:359-65.
7. Krausa P, Brywka M III, Savage D, Hui KM, Bunce M, Ngai JLF, et al. Genetic polymorphism within HLA-A*02: significant allelic variation revealed in different populations. Tissue Antigens 1995;45:223-31.
8. Date Y, Kimur A, Kato H, Sasazuki T. DNA typing of the HLA-A gene: population study and identification of four new alleles in Japanese. Tissue Antigens 1996;47:93-101.
9. Kimura A, Sasazuki T. Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique. In: Tsuji K, Aizawa M, Sasazuki T, editors. HLA 1991 Vol. 1. Oxford: Oxford University Press 1992;397-419.
10. Tarpley JL, Chretien PB, Rogentine GN, Twomey PL, Dellon AL. Histocompatibility antigens and solid malignant neoplasms. Arch Surg 1975;110:269-71.
11. Houck JR, Romano PJ, Bartholomew M, Smith PJ, Kloszewski F, Velsell ES. Do histocompatibility antigens influence the risk of head and neck carcinoma? Cancer 1997;69:2327-32.